Altimmune (ALT) Receives Award from U.S. Department of Defense to Fund Phase 1/2 Clinical Trial of T-COVID in Outpatients with Early COVID-19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Goldman warns high investor conviction could amplify volatility as sentiment shift
| iShares Diversified Alternatives Trust (NASDAQ: ALT) | Delayed: 2.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.20 | 52 Week High | $54.24 | |||
| Open | $2.20 | 52 Week Low | $48.35 | |||
| Day High | $2.20 | P/E | N/A | |||
| Day Low | $2.20 | EPS | $0.00 | |||
| Volume | 36,237 | |||||
